Highlights and Quick Summary
- Long Term Debt (Total) for the quarter ending June 30, 2022 was $1.28 Million (a 46.21% increase compared to previous quarter)
- Year-over-year quarterly Long Term Debt (Total) decreased by -45.81%
- Annual Long Term Debt (Total) for 2021 was $1.01 Million (a -4.17% decrease from previous year)
- Annual Long Term Debt (Total) for 2021 was $1.05 Million (a -95.95% decrease from previous year)
- Annual Long Term Debt (Total) for 2020 was $26 Million (a 1.66% increase from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long Term Debt (Total) of Biofrontera AG Sponsored ADR
Most recent Long Term Debt (Total)of BFAGY including historical data for past 10 years.Interactive Chart of Long Term Debt (Total) of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Long Term Debt (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $1.28 | $0.87 | – |
| 2021 | $0.97 | $2.36 | $25.35 | $25.12 | $1.01 |
| 2020 | $28.07 | $35.59 | $25.06 | $24.19 | $25.97 |
| 2019 | – | $24.84 | $24.67 | $23.87 | $24.76 |
| 2018 | – | – | – | $15.39 | $15.9 |
| 2017 | – | – | $14.98 | $9.22 | $13.96 |
| 2016 | $3.98 | – | – | – | $3.98 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic